Devdatt (Dev) Kurdikar

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when Embecta Corp. publishes a filing, an earnings call transcript or a press release.

Get EMBC alerts

About Devdatt (Dev) Kurdikar

Devdatt (Dev) Kurdikar is recorded as Chairman at Embecta Corp. (EMBC) since November 17, 2025. Embecta Corp. reported in an 8-K filed November 17, 2025 that Devdatt (Dev) Kurdikar was appointed Chairman of the Board. Devdatt (Dev) Kurdikar has spoken on 2 earnings calls across 1 company, most recently for Embecta Corp. on May 5, 2026. Embecta Corp. is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Embecta Corp. includes David F. Melcher (Chairman), Jacob Elguicze (CFO), Jeff Mann (General Counsel) and 7 others.

“The Company's independent directors expect to appoint Devdatt (Dev) Kurdikar as the Chairman of the Board and Dr. Claire Pomeroy as the Board's Lead Independent Director, each effective upon LTG Melcher's departure from the Board at the Company's 2026 annual meeting of stockholders.”

Embecta Corp. Form 8-K, filed November 17, 2025 · Read the filing

Devdatt (Dev) Kurdikar on recent calls

“I want to start the call by addressing our second quarter performance and full year guidance revision. This was a difficult quarter for MBETA. Our results were below expectations with consolidated revenues down 14.4% year-over-year on an as-reported basis or 17.4% on an adjusted constant currency basis.”

CEO, Embecta Corp. Q2 FY2026 Earnings Call · May 5, 2026

“Over the past year, and particularly since we reported our fiscal year 2025 results, we have continued to make meaningful progress executing our strategic roadmap we outlined at our investor day last year.”

CEO, Embecta Corp. Q1 FY2026 Earnings Call · February 5, 2026